使用基于合成数据训练的深度学习方法增强磁共振图像中对比剂的效果
研究提出用物理模型生成合成数据训练深度学习模型,以放大钆对比剂在MR图像中的对比效果;在大鼠脑胶质瘤临床前研究中验证后,应用于1990例脑疾病患者回顾性临床数据,虚拟对比图像较标准剂量图像的对比噪声比和病灶-脑比值分别平均提高155%和34%,两位神经放射学家盲评显示对小脑病灶的敏感度显著优于标准剂量图像(4.46/5 vs 3.51/5)。
要点
- 虚拟双倍剂量图像在7T和3T下与实验双倍剂量图像高度相似,且显著优于标准剂量(0.1 mmol Gd/kg)图像。
- 临床研究中虚拟对比图像的对比噪声比和病灶-脑比值较标准剂量图像分别平均提高155%和34%。
- 两位神经放射学家盲评显示AI增强图像对小脑病灶的敏感度显著优于标准剂量图像(4.46/5 vs 3.51/5)。
核心结论
- 物理模型生成的合成数据可有效训练深度学习模型进行对比增强放大,通过该方法可生成高于标准剂量钆对比剂所能达到的对比度,在检测小且低强化脑病灶方面具有显著优势。
研究设计与样本
- 临床前研究在大鼠脑胶质瘤模型多剂量对比剂MR研究中微调模型参数并评估虚拟对比图像与金标准MR及组织学数据的保真度,使用3T和7T两台扫描仪评估场强影响;随后扩展至回顾性临床研究,纳入1990例脑疾病患者(包括胶质瘤、多发性硬化、转移性癌症)的检查。
关键影像表现/征象
- 虚拟双倍剂量图像在7T下峰值信噪比为29.49 dB、结构相似性指数为0.914 dB,在3T下分别为31.32 dB和0.942 dB,与实验双倍剂量图像高度相似。
- 虚拟双倍剂量图像在两种场强下均显著优于标准对比剂量(即0.1 mmol Gd/kg)图像。
- 临床研究中虚拟对比图像的对比噪声比和病灶-脑比值较标准剂量图像分别平均提高155%和34%。
诊断标准与关键数值
- 虚拟对比图像与实验双倍剂量图像的相似度评估采用峰值信噪比(7T:29.49 dB;3T:31.32 dB)和结构相似性指数(7T:0.914 dB;3T:0.942 dB)。
- 临床图像评估指标包括对比噪声比、病灶-脑比值和定性评分。
- 两位神经放射学家盲评AI增强图像与标准剂量图像对小脑病灶的敏感度分别为4.46/5和3.51/5。
临床应用与阅片要点
- 该方法可生成高于标准剂量钆对比剂所能达到的对比度,用于检测小且低强化的脑病灶。
- 虚拟对比图像在3T和7T场强下均与实验双倍剂量图像高度相似,可用于评估场强对对比增强效果的影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Artificial intelligence (AI) methods can be applied to enhance contrast in diagnostic images beyond that attainable with the standard doses of contrast agents (CAs) normally used in the clinic, thus potentially increasing diagnostic power and sensitivity. Deep learning-based AI relies on training data sets, which should be sufficiently large and diverse to effectively adjust network parameters, avoid biases, and enable generalization of the outcome. However, large sets of diagnostic images acquired at doses of CA outside the standard-of-care are not commonly available. Here, we propose a method to generate synthetic data sets to train an "AI agent" designed to amplify the effects of CAs in magnetic resonance (MR) images. The method was fine-tuned and validated in a preclinical study in a murine model of brain glioma, and extended to a large, retrospective clinical human data set.
MATERIALS AND METHODS: A physical model was applied to simulate different levels of MR contrast from a gadolinium-based CA. The simulated data were used to train a neural network that predicts image contrast at higher doses. A preclinical MR study at multiple CA doses in a rat model of glioma was performed to tune model parameters and to assess fidelity of the virtual contrast images against ground-truth MR and histological data. Two different scanners (3 T and 7 T, respectively) were used to assess the effects of field strength. The approach was then applied to a retrospective clinical study comprising 1990 examinations in patients affected by a variety of brain diseases, including glioma, multiple sclerosis, and metastatic cancer. Images were evaluated in terms of contrast-to-noise ratio and lesion-to-brain ratio, and qualitative scores.
RESULTS: In the preclinical study, virtual double-dose images showed high degrees of similarity to experimental double-dose images for both peak signal-to-noise ratio and structural similarity index (29.49 dB and 0.914 dB at 7 T, respectively, and 31.32 dB and 0.942 dB at 3 T) and significant improvement over standard contrast dose (ie, 0.1 mmol Gd/kg) images at both field strengths. In the clinical study, contrast-to-noise ratio and lesion-to-brain ratio increased by an average 155% and 34% in virtual contrast images compared with standard-dose images. Blind scoring of AI-enhanced images by 2 neuroradiologists showed significantly better sensitivity to small brain lesions compared with standard-dose images (4.46/5 vs 3.51/5).
CONCLUSIONS: Synthetic data generated by a physical model of contrast enhancement provided effective training for a deep learning model for contrast amplification. Contrast above that attainable at standard doses of gadolinium-based CA can be generated through this approach, with significant advantages in the detection of small low-enhancing brain lesions.
引用
- Fringuello Mingo, Colombo Serra, Macula, et al. Amplifying the Effects of Contrast Agents on Magnetic Resonance Images Using a Deep Learning Method Trained on Synthetic Data. Invest Radiol. 2023. PMID: 37378418. doi:10.1097/RLI.0000000000000998
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。